| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/04/2009 | CN101375878A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375877A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375876A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375875A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 03/04/2009 | CN101375874A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375872A Novel medicament prescription for treating diabetes |
| 03/04/2009 | CN101375870A Compound creat injection and preparation method |
| 03/04/2009 | CN101375859A Compound composite medicament for preventing and treating iron-deficiency anemia and secondary infection of young stock |
| 03/04/2009 | CN101375858A Solid formulation of urea nitrogen sorbent for compensating kidney function and preparation method thereof |
| 03/04/2009 | CN101375857A Application of yew polysaccharide in preparing medicament for myocardial ischemia-reperfusion injury |
| 03/04/2009 | CN101375856A Compound ivermectin injection and preparation method |
| 03/04/2009 | CN101375855A Compound niacin norfloxacin injection and preparation method |
| 03/04/2009 | CN101375854A Medicinal preparation for treating osteoarthritis |
| 03/04/2009 | CN101375853A Hemorrhoid ointment and preparation method thereof |
| 03/04/2009 | CN101375852A Boletic acid quetiapine oral preparation and preparation method thereof |
| 03/04/2009 | CN101375851A Use of alkaloids compounds in preparing medicament for treating cough |
| 03/04/2009 | CN101375850A Application of norisoboldine in preparing medicament for treating autoimmune disease |
| 03/04/2009 | CN101375849A Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 03/04/2009 | CN101375848A Fluconazole eye gel |
| 03/04/2009 | CN101375847A Medicament composition with dehydration and diuresis functions |
| 03/04/2009 | CN101375846A Ellagic acid supermolecule composition and preparation method |
| 03/04/2009 | CN101375845A Podophyllotoxin external-use formulation prescription for treating pointed condyloma and herpes genitalis, dosage form series and preparation method |
| 03/04/2009 | CN101375844A Anti-depression medicament using salvianolic acid B as raw material and production method thereof |
| 03/04/2009 | CN101375843A Compound tranilast orally disintegrating tablet formulation and preparation method thereof |
| 03/04/2009 | CN101375842A Application of lignan of biphenyl cyclooctene series in preparing anti-hepatitis B virus medicament |
| 03/04/2009 | CN101375841A Daucane type sesquiterpenes and preparation method and application thereof |
| 03/04/2009 | CN101375840A Application of monocyclic monoterpene compounds in preparing medicament for treating diabetes |
| 03/04/2009 | CN101375839A Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/04/2009 | CN101375837A Medicament composition for treating dermatopathy as well as preparation method and use thereof |
| 03/04/2009 | CN101375836A Compound gentamicin-micronomicin injection and preparation method |
| 03/04/2009 | CN101375835A External-use sertaconazole nitrate suppositorium |
| 03/04/2009 | CN101375834A Solid dispersion of Ailamode and preparation method thereof and medicament application |
| 03/04/2009 | CN100465188C Novel antibiotic Chemomycin B, C, D and a preparation method thereof |
| 03/04/2009 | CN100465187C Upright datura flower steroid-lactone components, and a preparation and a pharmaceutical in antitumour medicines |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100465184C Gangliosides with a modified acyl function |
| 03/04/2009 | CN100465177C An oxygen, nitrogen heterocyclic naphthoyl imine kind compound and a biological application thereof |
| 03/04/2009 | CN100465175C A 7-bit substituted comptothecine kind compound and a pharmaceutical use thereof |
| 03/04/2009 | CN100465173C A selective kinase inhibitor |
| 03/04/2009 | CN100465172C A macrolide compound of Macrolactin Q with antibacterial activity |
| 03/04/2009 | CN100465171C A preparation method of potassium sodium dehydroandroan drographolide succinate, a potassium sodium dehydroandroan drographolide succinate preparation and a preparation method thereof |
| 03/04/2009 | CN100465164C A selective synthesis of CF3-substituted pyrimidines |
| 03/04/2009 | CN100465158C An amino-substituted ethylamino beta2- adrenergic receptor agonist |
| 03/04/2009 | CN100464789C A digestive tract stent with anti-cancer medicinal particles |
| 03/04/2009 | CN100464786C An ophthalmic composition for contact lens |
| 03/04/2009 | CN100464781C Nutrition liquid for chronic nephropathy and a preparation method thereof |
| 03/04/2009 | CN100464779C Hair-culturing alopecia-preventing liquid or hair-culturing nourishing liquid and a preparation method thereof |
| 03/04/2009 | CN100464764C A composition of white mulberry leaf blood-sugar-reducing effective components and a preparation method thereof |
| 03/04/2009 | CN100464760C An application of cocklebur fruit total glucoside extracts in preparing anti-inflammation reaction products |
| 03/04/2009 | CN100464756C An application of fucoidan in the preparation of medicines and health-care products for preventing and treating neurodegenerative diseases |
| 03/04/2009 | CN100464755C A traditional Chinese medicine preparation with functions of immunological regulation for anti-chemical damage |
| 03/04/2009 | CN100464754C Acarbose medicine compositions and a preparation method thereof |
| 03/04/2009 | CN100464753C Foscarnet sodium compositions |
| 03/04/2009 | CN100464752C Granisetron cataplasm and a preparation method thereof |
| 03/04/2009 | CN100464751C Matrine eye drip liquid and a production method thereof |
| 03/04/2009 | CN100464750C A method for preparing medicinal compounds with amoxicillin sodium and potassium clavulanate |
| 03/04/2009 | CN100464749C 5HT4 partial agonist pharmaceutical compositions |
| 03/04/2009 | CN100464748C An application of racemoid nor-poon essence A in the preparation of AIDS drugs |
| 03/04/2009 | CN100464747C A medicine composition with bailobalide |
| 03/04/2009 | CN100464746C A fishing antibacterial agent with Chinese medicine effective ingredients |
| 03/04/2009 | CN100464745C A medication composition of acetyl cysteine or a pharmaceutical salt thereof and asarin |
| 03/04/2009 | CN100464744C An orally disintegrated Ubenimex tablet and a preparation method thereof |
| 03/04/2009 | CN100464743C N-acetylcysteine compositions for the treatment and prevention of drug toxicity |
| 03/04/2009 | CN100464742C NF-kB activation inhibitors |
| 03/04/2009 | CN100464741C An aqueous-alcoholic depigmenting gel with phenolic derivatives and the vitamer A |
| 03/04/2009 | CN100464740C An osmotic pump controlled release tablet of solid dispersion of hydroxy camptothecin and a preparation method thereof |
| 03/04/2009 | CN100464738C A production method of pharmaceutical solid preparation with poorly soluble drugs |
| 03/04/2009 | CN100464737C A medicinal composition of nimustine and a synergist thereof |
| 03/04/2009 | CN100464736C A slow released anticancer injection with both antimetabolite and a synergist thereof |
| 03/04/2009 | CN100464647C A medical agent with amino acids that can increase body temperatures and be used in foods or beverages |
| 03/04/2009 | CN100464642C Health-care sand for compound palygorskite homing pigeons |
| 03/04/2009 | CA2697051A1 Substituted-quinoxaline-type piperidine compounds and the uses thereof |
| 03/03/2009 | US7498466 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 03/03/2009 | US7498465 Process for the synthesis and crystalline form of agomelatine |
| 03/03/2009 | US7498447 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted pyrrolidine compounds |
| 03/03/2009 | US7498445 4-Methyl-5-(-2-nitrooxy-ethyl)-2-(1-nitrooxy-ethyl)-thiazole for example; compound forms a naturally occurring metabolite when NO is released; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 03/03/2009 | US7498441 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment |
| 03/03/2009 | US7498440 1-(2-{[(3-fluorophenyl)methyl]oxy}ethyl)-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane bromide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498434 e.g. N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylpropanamide; reacting aminopyrazole compound with substituted 1-oxo-2-propenyl-arene(-heterocycle) under acidic conditions in reaction medium (two-phase mixture of aqueous solution and water-immiscible organic liquid); anxiolytic agent |
| 03/03/2009 | US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498361 Methods of treating tardive dyskinesia and other movement disorders |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | US7498359 Orally administering ethyl icosapentate (epadel) to a patient that has had a stroke at a dose of 0.3 to 6.0 g/day in combination with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498357 Chalcone compounds |
| 03/03/2009 | US7498356 Substituted amino carboxylic acids |
| 03/03/2009 | US7498355 e.g. 4- or 5-amino-2-hydroxy-benzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3-yl)-phenyl ester; hydrogen sulfide (H2S) releasing agent; anticarcinogenic agent; smooth muscle relaxant in intestinal tissues; intestinal diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) |
| 03/03/2009 | US7498354 Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disorders |
| 03/03/2009 | US7498353 e.g. tert-Butyl 6-(2-(3-(2,6-Dichlorophenyl)isoxazol-5-yl)pyridin-4-ylamino)-2-methyl-4-oxohexan-3-ylcarbamate; Hepatitis C virus (HCV) infections |
| 03/03/2009 | US7498352 TGF-β superfamily production/secretion promoter |
| 03/03/2009 | US7498351 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/03/2009 | US7498350 e.g. 3-(3-Fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyrid-3-yl)phenyl)-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one; methacillin resistant staphylococcus, streptococcus pneumoniae, Enterococcus faecium, Haemophillus influenzae, Moraxella catarrhalis and Linezolid resistant streptococcus pneumoniae |
| 03/03/2009 | US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 03/03/2009 | US7498348 treatment of obesity; administered with or without lipase inhibitor such as orlistat or lipstatin; e.g. N-cyclohexyl-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-5-(N-ethyl,N-methylaminomethyl)-1H-imidazole-4-carboxamide |
| 03/03/2009 | US7498347 improved metabolic stability; gastrointestinal conditions like hypermotility, irritable bowel syndrome (IBS), constipation or diarrhea; amidation |
| 03/03/2009 | US7498346 Chemokine receptor binding compounds |
| 03/03/2009 | US7498345 Process for production of piperidine derivatives |